Record Details

Contribution of Dopamine in Dopaminergic Neurodegeneration

EPrints@IICB

View Archive Info
 
 
Field Value
 
Title Contribution of Dopamine in Dopaminergic Neurodegeneration
 
Creator Borah, Anupom
 
Subject Cell Biology & Physiology
 
Description Parkinson’s disease (PD) is a neurodegenerative disorder characterized by progressive degeneration and loss of nigrostriatal dopaminergic neurons in the midbrain, leading to severe striatal dopamine (DA) depletion resulting in tremor, rigidity, and hypokinesia
(Carlsson, 2002). PD is named after James Parkinson who first described the disease as “Shaking Palsy” (Paralysis Agitans) in his classic monograph “An essay on the Shaking
Palsy” (Parkinson, 1817). He described the disease as “involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported; with a propensity to bend the trunk forwards, and to pass from a walking to a running pace: the senses and
intellects being uninjured”. Jean-Martin Charcot (1877) gave PD its present name and elaborated on the description of the disease given by James Parkinson (see Elmer, 2005).
Descriptions of the symptoms of PD were found mentioned as early as 5000 B.C in the ancient Indian medical treatise “Charakasamhitha” under the name Kampavata (kampa - tremors). It was also found mentioned in the first Chinese medical text, “Nei Jing”, about
2500 years ago, and in an Egyptian text (Garcia Ruiz, 2004). The only major contention presently is the perception of clinicians that in addition to motor impairments, behavioural dysfunction and cognitive impairment too contribute to the morbidity often seen in PD
patients.
 
Date 2009
 
Type Thesis
NonPeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/940/1/AnupomThesis.pdf
Borah, Anupom (2009) Contribution of Dopamine in Dopaminergic Neurodegeneration. PhD thesis, Jadavpur University.
 
Relation http://www.eprints.iicb.res.in/940/